Moreover, our data provide proof‐of‐concept evidence that targeting titin‐based VSMC tone through the RBM20‐titin axis may be beneficial for the treatment of cardiovascular diseases caused by or involving increased peripheral vascular resistance. The gene discussed is RBM20; the disease is cardiovascular disorder.